BRÈVE publiée le 16/04/2025 à 20:03, il y a 1 année 3 mois Askeladden Capital Pushes for Change at AstroNova Financial Performance Board Changes AstroNova Askeladden Capital Q4 2025
BRÈVE publiée le 16/04/2025 à 20:03, il y a 1 année 3 mois Askeladden Capital fait pression pour le changement chez AstroNova Performance Financière Changements Au Sein Du Conseil D'administration AstroNova Askeladden Capital T4 2025
COMMUNIQUÉ DE PRESSE publié le 16/04/2025 à 19:58, il y a 1 année 3 mois Askeladden Capital Comments on AstroNova Q4 and FY2025 Results AstroNova faces fourth consecutive quarter of poor performance, blames delays and covenant breach. Askeladden Capital nominates new directors to restore shareholder value Delays AstroNova Askeladden Capital Poor Performance Covenant Breach
Publié le 22/07/2026 à 18:19, il y a 2 heures 13 minutes Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 2 heures 13 minutes Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 2 heures 47 minutes Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 2 heures 47 minutes Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 2 heures 52 minutes Report on share repurchases from 15 to 21 July 2026
Publié le 22/07/2026 à 15:00, il y a 5 heures 32 minutes Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 5 heures 32 minutes Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:35, il y a 5 heures 57 minutes Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 6 heures 2 minutes As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Publié le 22/07/2026 à 20:08, il y a 24 minutes EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Publié le 22/07/2026 à 19:35, il y a 57 minutes Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026
Publié le 22/07/2026 à 19:29, il y a 1 heure 3 minutes EQS-Adhoc: Stabilus SE: Profit from operating activities and profit for the period significantly higher, adjusted FCF lower than in Q3 of the prior year; full-year forecast specified within the original ranges
Publié le 22/07/2026 à 18:30, il y a 2 heures 2 minutes EQS-Adhoc: Daimler Truck Holding AG: Daimler Truck Holding AG raises full-year guidance
